Alembic Pharmaceuticals Ltd. and Amlan International sign exclusive strategic commercial agreement to make poultry health innovations accessible to Indian farmers and integrators

– A strategic leap towards transformative growth in poultry production in India

Mumbai, India & Chicago, USA –  Alembic Pharmaceuticals Ltd., a leading Indian pharmaceutical company, and Amlan International, the animal health business of Oil-Dri Corporation of America, have entered into a strategic commercial agreement to introduce cutting-edge poultry health solutions to the Indian market. This collaboration will expand access to advanced feed additives that improve gut health, nutrient absorption, and feed conversion ratios (FCR), ensuring better poultry yields and supporting the industry’s growing demand for high-quality protein. It also establishes a framework for knowledge sharing, technical training, and sustainable growth in India’s poultry sector.

Congratulating both the teams on the occasion, Shaunak Amin, Managing Director, Alembic Pharmaceuticals Ltd., said, “At Alembic, we have always believed in driving innovation that creates real impact. Partnering with Amlan International is a step towards that goal, allowing us to bring scientifically backed, practical solutions to poultry farmers across India. With Amlan’s expertise in toxin binder & gut health, and with our strong presence in the market, we’re not just introducing new products, we’re addressing key challenges in poultry farming. Our long term goal is to improve efficiency and contribute towards a more sustainable future for the industry.”

With India’s growing need for sustainable poultry production, this partnership will introduce innovative, science-backed solutions to optimize poultry performance. P. Karunanithi, Executive Vice President (Cluster Head), Animal Health Division at Alembic Pharmaceuticals Ltd., commented: “Poultry production efficiency starts with a healthy intestinal environment. By integrating Amlan’s innovative feed additive technologies into our portfolio, we are strengthening our commitment to delivering science-backed solutions that enhance poultry health and performance.”

On signing of the commercial agreement, Dr. W. Wade Robey, VP Agriculture and President, Amlan International, USA added “This strong foundation of partnership will open the door with innovative and research based products broadly reaching India’s poultry and feed milling sector. It is a pleasure for Amlan International to collaborate with Alembic Pharmaceuticals India that has a strong legacy with a global footprint. This agreement will lay the framework for cultivating success through strong collaboration, continuous learning, knowledge sharing, and an innovative range of products to enhance poultry productivity.”

This strategic alliance reinforces the commitment of Alembic Pharmaceuticals Ltd. and Amlan International to advancing poultry health, enhancing efficiency, and ensuring long-term industry growth in India.

About Alembic Pharmaceuticals Limited:

Alembic Pharmaceuticals Limited, a vertically integrated research and development pharmaceutical company, has been at the forefront of healthcare since 1907. Headquartered in India, Alembic is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world. Alembic’s state-of-the-art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the USFDA. Alembic is one of the leaders in branded generics in India. Alembic’s brands, marketed through a field force of over 5200 are well recognized by doctors and patients.

Information about the Company can be found at www.alembicpharmaceuticals.com; (Reuters: ALEM.NS) (Bloomberg: ALPM) (NSE: APLLTD) (BSE: 533573)

About Amlan International:

Amlan International is the animal health business of Oil-Dri Corporation of America, a global leader in sorbent mineral technology with over 80 years of expertise in mineral science. Oil-Dri selectively mines and processes its unique minerals for both consumer and business markets. Oil-Dri Corporation of America (NYSE: ODC) operates Amlan International, which sells feed additives worldwide. Product availability may vary by country, and claims associated with Amlan’s products comply with relevant regulatory requirements.

For media queries:

For Alembic Pharmaceuticals Ltd.

Nitin Kinger,
Senior Manager- Corporate Communications
Nitin.kinger@alembic.co.in